Morena en es it fr

Morena Brand names, Morena Analogs

Morena Brand Names Mixture

  • No information avaliable

Morena Chemical_Formula

C33H37N5O5

Morena RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Morena fda sheet

Morena FDA

Morena msds (material safety sheet)

Morena MSDS

Morena Synthesis Reference

No information avaliable

Morena Molecular Weight

583.678 g/mol

Morena Melting Point

No information avaliable

Morena H2O Solubility

No information avaliable

Morena State

Solid

Morena LogP

No information avaliable

Morena Dosage Forms

Liquid

Morena Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Morena Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Morena Absorption

Interpatient variable and may be dependent on the administration technique

Morena side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Morena Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Morena Organisms Affected

Humans and other mammals